Clinical Trials Browser

Unknown × tositumomab I-131 × Clear all

NCT00022880 2005-06-24

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00022893 2005-06-24

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT00022906 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT00022932 2005-06-24

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT00022958 2005-06-24

Expanded Access Study of Iodine-131 Anti-B1 Antibody

Phase NA Unknown

Lymphoma, Non-Hodgkin